The Role of Age in Delays to Rheumatological Care in Juvenile Idiopathic Arthritis

J Rheumatol. 2022 Sep;49(9):1037-1041. doi: 10.3899/jrheum.211316. Epub 2022 Apr 1.


Objective: To investigate the relationship between age and symptom duration at initial presentation to pediatric rheumatology for juvenile idiopathic arthritis (JIA).

Methods: In children and young people (CYP) enrolled in the Childhood Arthritis Prospective Study prior to March 2018, an association between age at presentation (< 5, 5-11, and > 11 yrs) and symptom duration was tested by multivariable linear regression.

Results: In 1577 CYP, 5- to 11-year-olds took 3.2 months longer and > 11-year-olds 6.9 months longer to reach pediatric rheumatology than < 5-year-olds.

Conclusion: Adolescents take longer to reach pediatric rheumatology, potentially affecting their longer-term outcomes given the window of opportunity for JIA treatment.

Keywords: adolescent rheumatology; age; juvenile idiopathic arthritis; pediatric rheumatology; symptom duration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Arthritis, Juvenile* / diagnosis
  • Arthritis, Juvenile* / drug therapy
  • Child
  • Child, Preschool
  • Humans
  • Prospective Studies
  • Rheumatology*